HCA Healthcare Inc (NYSE:HCA) Announces $0.40 Quarterly Dividend

HCA Healthcare Inc (NYSE:HCA) announced a quarterly dividend on Tuesday, October 29th, Zacks reports. Shareholders of record on Monday, December 2nd will be given a dividend of 0.40 per share on Friday, December 27th. This represents a $1.60 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date is Friday, November 29th.

HCA opened at $138.90 on Wednesday. The company has a fifty day moving average price of $130.46 and a two-hundred day moving average price of $128.53. HCA Healthcare has a 52 week low of $110.31 and a 52 week high of $147.42. The firm has a market capitalization of $47.21 billion, a PE ratio of 14.22, a P/E/G ratio of 1.18 and a beta of 0.90.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 29th. The company reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The firm had revenue of $12.69 billion during the quarter, compared to analyst estimates of $12.48 billion. During the same quarter in the previous year, the business earned $2.16 EPS. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. Equities analysts forecast that HCA Healthcare will post 10.53 earnings per share for the current fiscal year.

A number of analysts have commented on HCA shares. Robert W. Baird lifted their target price on shares of HCA Healthcare from $155.00 to $160.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. ValuEngine raised shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Bank of America lifted their price target on shares of HCA Healthcare from $145.00 to $150.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 20th. Stephens set a $150.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, Mizuho set a $153.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. HCA Healthcare currently has an average rating of “Buy” and an average target price of $156.00.

In related news, SVP Christopher F. Wyatt sold 3,900 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $134.74, for a total value of $525,486.00. Following the sale, the senior vice president now directly owns 27,353 shares of the company’s stock, valued at approximately $3,685,543.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jon M. Foster sold 19,477 shares of the business’s stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $132.35, for a total transaction of $2,577,780.95. Following the completion of the sale, the insider now directly owns 10,015 shares in the company, valued at $1,325,485.25. The disclosure for this sale can be found here. Over the last three months, insiders have sold 40,571 shares of company stock worth $5,431,851. Insiders own 2.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What is meant by a buy rating?

Dividend History for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.